ARCHIVES

Imbruvica Improves PFS, OS In Phase III CLL Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: William Peters To Leave Duke To Head Michigan Cancer Foundation, Prentis Center

April 7, 1995

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

July 31, 2009

Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research

April 27, 1979

NCI Programs: Institute Renews 10 Center Grants, Provides Complete Grant List.

January 28, 2005

Letters: NCI Mammography Statement Recognizes Patient Autonomy

February 25, 1994

New Journal Examines Claims Of Proponents Of Alternative Medicine

October 24, 1997